REPORT ID 5225

Asia-Pacific Anti-epileptic Drugs for Pediatrics Market Report 2017

Publish Date
20-Dec-17
Pages
117
Format
Electronic (PDF)

In this report, the Asia-Pacific Anti-epileptic Drugs for Pediatrics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Anti-epileptic Drugs for Pediatrics for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Anti-epileptic Drugs for Pediatrics market competition by top manufacturers/players, with Anti-epileptic Drugs for Pediatrics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Mylan N.V.
    Cephalon, Inc.
    GlaxoSmithKline plc
    Janssen Pharmaceuticals
    Novartis AG
    Pfizer, Inc.
    Sanofi S.A.
    UCB Pharma Limited
    Sunovion Pharmaceuticals Limited
    Valeant Pharmaceuticals International, Inc.
    Zogenix
    GW Pharmaceuticals
    Insys
    Zynerba

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    First Generation
    Second Generation
    Third Generation

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Clinic
    Hospital
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Anti-epileptic Drugs for Pediatrics Market Report 2017
1 Anti-epileptic Drugs for Pediatrics Overview
    1.1 Product Overview and Scope of Anti-epileptic Drugs for Pediatrics
    1.2 Classification of Anti-epileptic Drugs for Pediatrics by Product Category
        1.2.1 Asia-Pacific Anti-epileptic Drugs for Pediatrics Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Anti-epileptic Drugs for Pediatrics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 First Generation
        1.2.4 Second Generation
        1.2.5 Third Generation
    1.3 Asia-Pacific Anti-epileptic Drugs for Pediatrics Market by Application/End Users
        1.3.1 Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Asia-Pacific Anti-epileptic Drugs for Pediatrics Market by Region
        1.4.1 Asia-Pacific Anti-epileptic Drugs for Pediatrics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Anti-epileptic Drugs for Pediatrics (2012-2022)
        1.5.1 Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Anti-epileptic Drugs for Pediatrics Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Anti-epileptic Drugs for Pediatrics Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Anti-epileptic Drugs for Pediatrics (Volume and Value) by Type
        2.2.1 Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Anti-epileptic Drugs for Pediatrics (Volume) by Application
    2.4 Asia-Pacific Anti-epileptic Drugs for Pediatrics (Volume and Value) by Region
        2.4.1 Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue and Market Share by Region (2012-2017)

3 China Anti-epileptic Drugs for Pediatrics (Volume, Value and Sales Price)
    3.1 China Anti-epileptic Drugs for Pediatrics Sales and Value (2012-2017)
        3.1.1 China Anti-epileptic Drugs for Pediatrics Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2012-2017)
        3.1.3 China Anti-epileptic Drugs for Pediatrics Sales Price Trend (2012-2017)
    3.2 China Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Type
    3.3 China Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Application

4 Japan Anti-epileptic Drugs for Pediatrics (Volume, Value and Sales Price)
    4.1 Japan Anti-epileptic Drugs for Pediatrics Sales and Value (2012-2017)
        4.1.1 Japan Anti-epileptic Drugs for Pediatrics Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Anti-epileptic Drugs for Pediatrics Sales Price Trend (2012-2017)
    4.2 Japan Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Type
    4.3 Japan Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Application

5 South Korea Anti-epileptic Drugs for Pediatrics (Volume, Value and Sales Price)
    5.1 South Korea Anti-epileptic Drugs for Pediatrics Sales and Value (2012-2017)
        5.1.1 South Korea Anti-epileptic Drugs for Pediatrics Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Anti-epileptic Drugs for Pediatrics Sales Price Trend (2012-2017)
    5.2 South Korea Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Type
    5.3 South Korea Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Application

6 Taiwan Anti-epileptic Drugs for Pediatrics (Volume, Value and Sales Price)
    6.1 Taiwan Anti-epileptic Drugs for Pediatrics Sales and Value (2012-2017)
        6.1.1 Taiwan Anti-epileptic Drugs for Pediatrics Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Anti-epileptic Drugs for Pediatrics Sales Price Trend (2012-2017)
    6.2 Taiwan Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Type
    6.3 Taiwan Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Application

7 India Anti-epileptic Drugs for Pediatrics (Volume, Value and Sales Price)
    7.1 India Anti-epileptic Drugs for Pediatrics Sales and Value (2012-2017)
        7.1.1 India Anti-epileptic Drugs for Pediatrics Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2012-2017)
        7.1.3 India Anti-epileptic Drugs for Pediatrics Sales Price Trend (2012-2017)
    7.2 India Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Type
    7.3 India Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Application

8 Southeast Asia Anti-epileptic Drugs for Pediatrics (Volume, Value and Sales Price)
    8.1 Southeast Asia Anti-epileptic Drugs for Pediatrics Sales and Value (2012-2017)
        8.1.1 Southeast Asia Anti-epileptic Drugs for Pediatrics Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Anti-epileptic Drugs for Pediatrics Sales Price Trend (2012-2017)
    8.2 Southeast Asia Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Type
    8.3 Southeast Asia Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Application

9 Australia Anti-epileptic Drugs for Pediatrics (Volume, Value and Sales Price)
    9.1 Australia Anti-epileptic Drugs for Pediatrics Sales and Value (2012-2017)
        9.1.1 Australia Anti-epileptic Drugs for Pediatrics Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Anti-epileptic Drugs for Pediatrics Sales Price Trend (2012-2017)
    9.2 Australia Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Type
    9.3 Australia Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share by Application

10 Asia-Pacific Anti-epileptic Drugs for Pediatrics Players/Suppliers Profiles and Sales Data
    10.1 Mylan N.V.
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Mylan N.V. Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Cephalon, Inc.
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Cephalon, Inc. Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 GlaxoSmithKline plc
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Janssen Pharmaceuticals
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Novartis AG
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Novartis AG Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Pfizer, Inc.
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Pfizer, Inc. Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Sanofi S.A.
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Sanofi S.A. Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 UCB Pharma Limited
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Sunovion Pharmaceuticals Limited
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Valeant Pharmaceuticals International, Inc.
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Valeant Pharmaceuticals International, Inc. Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Zogenix
    10.12 GW Pharmaceuticals
    10.13 Insys
    10.14 Zynerba

11 Anti-epileptic Drugs for Pediatrics Manufacturing Cost Analysis
    11.1 Anti-epileptic Drugs for Pediatrics Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Anti-epileptic Drugs for Pediatrics

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Anti-epileptic Drugs for Pediatrics Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Anti-epileptic Drugs for Pediatrics Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Anti-epileptic Drugs for Pediatrics Market Forecast (2017-2022)
    15.1 Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Anti-epileptic Drugs for Pediatrics Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Anti-epileptic Drugs for Pediatrics Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Anti-epileptic Drugs for Pediatrics Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Anti-epileptic Drugs for Pediatrics Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Anti-epileptic Drugs for Pediatrics Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Anti-epileptic Drugs for Pediatrics Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Anti-epileptic Drugs for Pediatrics Sales, Revenue and Growth